Newcastle’s pioneering advanced therapies service has reached the finals for Laboratory of the Year and Team of the Year in the Institute of Biomedical Science Awards 2024.
One of the leading centres in advanced therapies and bone marrow stem cell transplantation, the team of 24 led by director Mark Jarvis works closely with clinicians and researchers to process and manufacture cells, genes and tissue products.
These therapies offer a new era of personalised medicine and innovative patient care. They are life changing for patients and are also used in commercial trials and research to keep driving forward medical advances and personalised care for patients.
At Newcastle Hospitals we’re recognised nationally and internationally as a leading centre for the implementation and delivery of advanced therapies.
Our scientists, clinicians and researchers have significant expertise in the development and production of high-quality advanced therapy products such as CAR T-cell therapy.
From the specialist laboratories at Newcastle University Medical School and the Centre for Life the team has a cutting-edge portfolio including:
➡ The haematology transplant service which treats over 300 patients per year and is an essential support to the Great North Children’s Hospital and the Northern Centre for Cancer Care.
➡ A specialist laboratory delivering bench-to-bedside programmes and supporting the translation of academic research through validation and process engineering to enable first-in-human trials.
➡ Trials include rheumatoid arthritis, myocardial infarction, limbal stem cell deficiency and anti-viral T-cells.
➡ CAR T therapy, the centre is one of the largest providers in the UK and has delivered its 100th product.
The dedication of staff in delivering excellent patient care has been recognised in the shortlisting. The winners will be announced at an awards ceremony on June 28 at The Brewery in London.
Newcastle Hospitals and Newcastle University are partners in Newcastle Health Innovation Partnership (NHIP) delivering collaborative health and care research, innovation, education and training.
